• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Health In Tech Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    4/29/25 4:30:08 PM ET
    $HIT
    Specialty Insurers
    Finance
    Get the next $HIT alert in real time by email
    false 0002019505 0002019505 2025-04-28 2025-04-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    Current Report

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    April 28, 2025

    Date of Report (Date of earliest event reported)

     

    Health In Tech, Inc.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-42449   87-3545722
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    701 S. Colorado Ave, Suite 1

    Stuart, FL

      34994
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (888) 373-0333

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Class A Common Stock, $0.001 par value per share   HIT  

    The Nasdaq Stock Market LLC

    (Nasdaq Capital Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On April 28, 2025, Health In Tech, Inc. (the “Company”) received a letter (the “Nasdaq Staff Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the closing bid price for the Company’s Class A common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

     

    In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until October 27, 2025, to regain compliance. The letter states that the Nasdaq staff will provide written notification that the Company has achieved compliance with Rule 5550(a)(2) if at any time before October 27, 2025, the bid price of the Company’s Class A common stock closes at $1.00 per share or more for a minimum of ten (10) consecutive business days. The Nasdaq Staff Letter has no immediate effect on the listing or trading of the Company’s Class A common stock.

     

    The Company intends to monitor the bid price of its Class A common stock and consider available options if its Class A common stock does not trade at a level likely to result in the Company regaining compliance with Nasdaq’s minimum bid price rule by October 27, 2025.

     

    If the Company does not regain compliance with Rule 5550(a)(2) by October 27, 2025, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period, for example, by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq would notify the Company that its securities would be subject to delisting. In the event of such a notification, the Company may appeal the Nasdaq staff’s determination to delist its securities. There can be no assurance that the Company will be eligible for the additional 180 calendar day compliance period, if applicable, or that the Nasdaq staff would grant the Company’s request for continued listing subsequent to any delisting notification.

     

    Forward-Looking Statements

     

    This current report contains “forward-looking statements” within the meaning of the U.S. federal securities laws. Forward-looking statements can be identified by words such as “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar references to future periods. Examples of forward-looking statements in this current report include, without limitation, statements regarding the Company’s intent to monitor the bid price of its Class A common stock and consider available options, including a reverse stock split; and the Company’s eligibility for an additional 180 calendar day compliance period. Forward-looking statements are statements that are not historical facts, nor assurances of future performance. Instead, they are based on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties, and actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual results to differ include, without limitation, there can be no assurance that the Company will meet the bid price requirement during any compliance period or otherwise in the future, otherwise meet Nasdaq compliance standards, that Nasdaq will grant the Company any relief from delisting as necessary or whether the Company can agree to or ultimately meet applicable Nasdaq requirements for any such relief, and the other important factors described under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2025, and its other filings with the SEC. Any forward-looking statement made by the Company in this current report is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: April 29, 2025

     

    HEALTH IN TECH, INC.

     

    By: /s/ Tim Johnson  
    Name:   Tim Johnson  
    Title: Chief Executive Officer  

     

     

    2

     

    Get the next $HIT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HIT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HIT
    Financials

    Live finance-specific insights

    See more
    • Health In Tech Announces First Quarter 2025 Financial Results

      Revenues increased 56% over the first quarter 2024 to $8.0 million, reflecting strong market demandIncome before income taxes more than tripled to $0.7 million, up 257% over the first quarter 2024Cash position remained strong at $7.6 million as of March 31, 2025STUART, Fla., April 14, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the first quarter ended March 31, 2025. Financial Highlights for the First Quarter of 2025 The number of enrolled employees (EEs) billed w

      4/14/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech to Announce First Quarter 2025 Financial Results on April 14, 2025

      STUART, Fla., April 8, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that it will release financial results for the quarter ended March 31, 2025, following the close of market on Monday, April 14, 2025. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent development and business outlook. Event: Health In Tech's 2025 First Quarter Earnings Conference CallWhen: Monday, April 14, 2025, at 5:00 p.m. ET Live Call:PARTICIPANT DIAL IN (TOLL

      4/8/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

      STUART, Fla., March 7, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, following the close of market on Monday, March 17, 2025. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent development and business outlook. Event: Health In Tech's 2024 Fourth Quarter and Full Year Earnings Conference Call When: Monday, March 17, 2025, at 5:00 p.m

      3/7/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Health In Tech Inc.

      10-Q - Health In Tech, Inc. (0002019505) (Filer)

      5/9/25 4:38:57 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Health In Tech, Inc. (0002019505) (Filer)

      4/29/25 4:30:08 PM ET
      $HIT
      Specialty Insurers
      Finance
    • SEC Form S-8 filed by Health In Tech Inc.

      S-8 - Health In Tech, Inc. (0002019505) (Filer)

      4/18/25 4:30:41 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Health In Tech to Participate as Gold Sponsor at American Trust Investment Services National Conference 2025

      STUART, Fl., May 20, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that CEO Tim Johnson and CFO Julia Qian will represent the company as a Gold Sponsor at the American Trust Investment Services National Conference 2025, to be held June 16–18, 2025, at the Andaz Hotel in San Diego, California. Hosted by American Trust Investment Services, this exclusive event will bring together registered representatives, advisors, and preferred sponsors for an immersive three-day conference focused on busin

      5/20/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech to Participate in the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd at 4:00 p.m. EDT

      STUART, Fla., May 13, 2025 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, announced today that the Company's CFO, Julia Qian, has been invited to present at the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow," hosted by Maxim Group LLC. The conference will take place from Tuesday, June 3rd to Thursday, June 5th, beginning each day at 9:00 a.m. EDT. Health In Tech is scheduled to present on Tuesday, June 3rd at 4:00 p.m. EDT. The rapid evolution of technology is paving the way for

      5/13/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Appoints Former U.S. Ambassador Edward McMullen to Advisory Board

      STUART, Fla., April 30, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce the appointment of Edward T. McMullen Jr., former U.S. Ambassador to Switzerland and Liechtenstein, as a member of its newly formed Advisory Board, effective immediately. Mr. McMullen brings decades of experience in diplomacy, public affairs, and strategic policy, enhancing the company's mission to revolutionize healthcare insurance infrastructure. "Health In Tech is honored to welcome Mr. McMullen to our Advisory Board," said Tim Johnson, Chairman & CEO of Health In Tech. "His deep expertise in public affairs, government relations

      4/30/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Leadership Updates

    Live Leadership Updates

    See more
    • Health In Tech to Participate as Gold Sponsor at American Trust Investment Services National Conference 2025

      STUART, Fl., May 20, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that CEO Tim Johnson and CFO Julia Qian will represent the company as a Gold Sponsor at the American Trust Investment Services National Conference 2025, to be held June 16–18, 2025, at the Andaz Hotel in San Diego, California. Hosted by American Trust Investment Services, this exclusive event will bring together registered representatives, advisors, and preferred sponsors for an immersive three-day conference focused on busin

      5/20/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Appoints Former U.S. Ambassador Edward McMullen to Advisory Board

      STUART, Fla., April 30, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce the appointment of Edward T. McMullen Jr., former U.S. Ambassador to Switzerland and Liechtenstein, as a member of its newly formed Advisory Board, effective immediately. Mr. McMullen brings decades of experience in diplomacy, public affairs, and strategic policy, enhancing the company's mission to revolutionize healthcare insurance infrastructure. "Health In Tech is honored to welcome Mr. McMullen to our Advisory Board," said Tim Johnson, Chairman & CEO of Health In Tech. "His deep expertise in public affairs, government relations

      4/30/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Announces Appointment of Sanjay Shrestha to Board of Directors

      STUART, Fla., April 10, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce the appointment of a new independent director, Sanjay Shrestha, to the Company's Board of Directors (the "Board"). Mr. Shrestha will serve as a member of the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee of the Board. "We are pleased to welcome Sanjay Shrestha to our Board of Directors," said Tim Johnson, Chairman & CEO of Health In Tech. "Sanjay brings a wealth of exp

      4/10/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Shrestha Sanjay K

      3 - Health In Tech, Inc. (0002019505) (Issuer)

      4/10/25 9:42:13 PM ET
      $HIT
      Specialty Insurers
      Finance
    • New insider Guerrica Jennifer claimed ownership of 28,500 shares (SEC Form 3)

      3 - Health In Tech, Inc. (0002019505) (Issuer)

      4/2/25 7:00:17 PM ET
      $HIT
      Specialty Insurers
      Finance
    • New insider Kurtenbach Chris Allen claimed ownership of 10,000 shares (SEC Form 3)

      3 - Health In Tech, Inc. (0002019505) (Issuer)

      3/27/25 9:58:48 PM ET
      $HIT
      Specialty Insurers
      Finance